Physician profile
Michael Rosen
NPI 1639419971
$14,706.58
in general payments reported to CMS, 2019-2025
12 companies · $5,393 in 2025
The $5,393 reported for 2025 was more than what 83% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,133 · 2020: $16.75 · 2021: $34.96 · 2022: $133 · 2023: $946 · 2024: $49.79 · 2025: $5,393.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,584 · Food and Beverage: $1,806 · Education: $999.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,584.14 |
| Food and Beverage | $1,805.79 |
| Education | $998.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $3,708.84 | 2019-2025 | |
| Medical Device Business Services, INC. | $2,316.23 | 2019-2025 | Inhance, Velys |
| Smith+Nephew, INC. | $2,239.56 | 2019-2022 | |
| Zimmer Biomet Holdings, INC. | $1,932.41 | 2023-2025 | Oxford, Oxford Partial Knee, Persona |
| Stryker Corporation | $1,839.52 | 2019-2025 | Blueprint Patient Specific Instrumentation, Mako, Triathlon |
| Depuy Synthes Sales INC. | $1,564.14 | 2019-2025 | Inhance, Na, Tfn-Advance |
| Mf Med | $869.16 | 2025 | |
| Osteoremedies, LLC | $172.50 | 2025 | Remedy Spacer, Biobrush, Osteoboost Select 5cc |
| Orthofix Medical, INC. | $18.99 | 2024 | Physio-Stim |
| Vericel Corporation | $18.98 | 2019 | |
| Acelrx Pharmaceuticals, INC. | $14.33 | 2021 | |
| Fx Shoulder Solutions, INC | $11.92 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Rosen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.